Bulk Equivalent To Sigma Sml2577 For Gmp Scale-Up
Comparative Analysis of Heavy Metal and Residual Solvent Profiles Against Sigma SML2577 Standards per ICH Q3C
When transitioning from analytical-scale Sigma SML2577 to bulk Pixantrone for GMP manufacturing, procurement managers must rigorously evaluate the impurity profile. Our Pixantrone (CAS 144510-96-3), also known as BBR 2778, is manufactured under strict controls to align with ICH Q3C guidelines for residual solvents and ICH Q3D for elemental impurities. A direct comparison of typical batch data shows that our material consistently meets the same limits as the reference standard. For instance, palladium content, a common catalyst residue in the synthesis of 6,9-Bis[(2-aminoethyl)amino]benz[g]isoquinoline-5,10-dione, is controlled below 10 ppm, matching the specification of Sigma SML2577. Residual solvents such as dichloromethane and methanol are monitored to ensure they are within the concentration limits defined for Class 2 solvents. However, one non-standard parameter we have observed in field use is a slight batch-dependent variation in the color of the dry powder, ranging from deep blue to blue-black, which does not correlate with purity but can be mistaken for degradation. This is due to trace polymorphic forms of the 5,8-Bis((2-aminoethyl)amino)-2-aza-anthracene-9,10-dione chromophore and is fully addressed in our COA documentation. For a seamless drop-in replacement for BBR-2778 in late-stage oncology synthesis, we provide a detailed residual solvent profile by headspace GC-MS and elemental analysis by ICP-MS with every shipment.
| Parameter | Sigma SML2577 Specification | Our Bulk Pixantrone Typical Value |
|---|---|---|
| Assay (HPLC) | ≥98% | ≥99.0% |
| Palladium (Pd) | ≤10 ppm | ≤5 ppm |
| Residual Solvents | Meets ICH Q3C | Meets ICH Q3C |
| Water Content (KF) | ≤1.0% | ≤0.5% |
Particle Size Distribution Control and Its Impact on Downstream Tablet Compression Performance
In GMP scale-up, the physical characteristics of the active pharmaceutical ingredient are as critical as its chemical purity. Our bulk Pixantrone is micronized to a controlled particle size distribution (PSD) that mirrors the performance benchmark of Sigma SML2577. Typical D50 values range from 5 to 15 µm, with D90 below 30 µm, ensuring adequate flowability and compressibility for direct compression formulations. We have extensive field experience with a non-standard behavior: at sub-zero temperatures during shipping or storage, the micronized powder can exhibit increased cohesiveness and a temporary shift in bulk density, which may affect hopper flow if not equilibrated to room temperature before processing. This is a common phenomenon with high-surface-area APIs and is mitigated by our moisture-barrier packaging. Our technical support team can provide a formulation guide to adjust glidant levels if needed. For those evaluating a substituto direto para BBR-2778 na síntese oncológica, we offer particle size analysis by laser diffraction as part of the COA, ensuring batch-to-batch consistency for tablet compression.
Moisture Ingress Barriers and Packaging Specifications for 25kg Drum Storage to Maintain Assay Purity
Pixantrone is hygroscopic and sensitive to hydrolysis, which can lead to degradation and loss of assay. To maintain the integrity of the bulk material during storage and transit, we employ a robust packaging system. Our standard offering is a 25kg fiber drum with a double LDPE liner and a desiccant bag between the liners. The drum is sealed under nitrogen to displace oxygen and moisture. This configuration has been validated to maintain assay purity above 99% for at least 24 months under recommended storage conditions (2-8°C, protected from light). For larger quantities, we can supply in 210L steel drums with similar inert atmosphere protection. We do not use IBCs for this product due to the risk of moisture ingress over extended storage. It is important to note that while our packaging is designed for global logistics, we make no claims regarding specific environmental certifications. Our focus is on physical protection of the API. Please refer to the batch-specific COA for the actual water content at release and retest dates.
Batch-to-Batch Consistency and COA Parameter Alignment for Seamless GMP Scale-Up
A critical concern for procurement managers is the ability to use the bulk material as a true drop-in replacement without revalidation of the entire process. We achieve this by aligning our COA parameters with those of Sigma SML2577. Each batch is tested for appearance, identity (IR, HPLC), assay, related substances, water content, residual solvents, elemental impurities, and particle size distribution. Our specification limits are set to match or exceed the reference standard. For example, the total impurity limit is ≤1.0%, with no single unknown impurity exceeding 0.10%. We have observed that the primary related substance, the des-ethyl analog, is consistently below 0.5%, which is comparable to the reference. To facilitate your internal auditing, we provide a comprehensive technical support package including the certificate of analysis, MSDS, and a statement of GMP compliance. Our global manufacturer status ensures a reliable supply chain for clinical and commercial production.
Supply Chain Reliability and Cost Efficiency as a Drop-in Replacement for Sigma SML2577
Switching to a bulk equivalent from a specialized manufacturer offers significant cost advantages without compromising quality. Our Pixantrone is produced in dedicated GMP facilities with annual capacity to support late-phase clinical trials and commercial launch. By sourcing directly from the global manufacturer, you eliminate the premium associated with catalog distributors. We maintain safety stock of key intermediates to ensure lead times of 4-6 weeks for typical orders. For urgent requirements, expedited synthesis may be available. Our drop-in replacement strategy is backed by a commitment to supply chain transparency: we provide full documentation on the synthetic route, starting materials, and critical process parameters. This enables a smooth technology transfer and minimizes regulatory risk. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.
Frequently Asked Questions
How can I audit the COA data for heavy metals and residual solvents when transitioning from analytical-scale SML2577 to bulk GMP production?
We provide a detailed COA with every batch that includes results for elemental impurities by ICP-MS (following USP <232>/<233> or ICH Q3D) and residual solvents by GC-MS (ICH Q3C). You can compare these directly with the Sigma SML2577 certificate. We also offer a pre-shipment sample for your in-house QC testing to confirm equivalence before committing to a full batch.
What is the typical lead time for a 25kg drum of Pixantrone, and how do you ensure supply chain reliability?
Our standard lead time is 4-6 weeks from order confirmation. We hold strategic reserves of key intermediates to mitigate supply disruptions. For larger or repeated orders, we can establish a vendor-managed inventory program to align with your production schedule.
Can you provide a formulation guide for using your Pixantrone in a lyophilized or tablet dosage form?
Yes, our technical support team can share a formulation guide based on our experience with various dosage forms. This includes recommendations on excipient compatibility, processing parameters, and stability-indicating methods. We can also assist with forced degradation studies to support your ANDA or NDA filing.
Is your Pixantrone manufactured under GMP conditions, and what documentation do you provide for regulatory filings?
Our Pixantrone is produced in accordance with ICH Q7 GMP guidelines for active pharmaceutical ingredients. We provide a full documentation package including the master batch record, certificate of analysis, MSDS, and a letter of GMP compliance. A drug master file (DMF) is available for reference in your regulatory submissions.
Sourcing and Technical Support
As a dedicated manufacturer of high-potency APIs, we understand the stringent requirements of oncology drug development. Our Pixantrone is designed as a seamless drop-in replacement for Sigma SML2577, offering equivalent quality with the cost and supply chain benefits of a bulk supplier. We invite you to review our technical data package and discuss your specific scale-up needs. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.